- Home
- BLCO vs ACLX Comparison
BLCO vs ACLX Comparison
Compare BLCO & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLCO
- ACLX
- Stock Information
- Founded
- BLCO 1853
- ACLX 2015
- Country
- BLCO Canada
- ACLX United States
- Employees
- BLCO N/A
- ACLX N/A
- Industry
- BLCO Ophthalmic Goods
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- BLCO Health Care
- ACLX Health Care
- Exchange
- BLCO Nasdaq
- ACLX Nasdaq
- Market Cap
- BLCO 4.9B
- ACLX 4.1B
- IPO Year
- BLCO 2022
- ACLX 2022
- Fundamental
- Price
- BLCO $15.23
- ACLX $75.20
- Analyst Decision
- BLCO Hold
- ACLX Strong Buy
- Analyst Count
- BLCO 11
- ACLX 13
- Target Price
- BLCO $15.80
- ACLX $114.75
- AVG Volume (30 Days)
- BLCO 492.5K
- ACLX 526.7K
- Earning Date
- BLCO 10-29-2025
- ACLX 11-06-2025
- Dividend Yield
- BLCO N/A
- ACLX N/A
- EPS Growth
- BLCO N/A
- ACLX N/A
- EPS
- BLCO N/A
- ACLX N/A
- Revenue
- BLCO $4,891,000,000.00
- ACLX $56,979,000.00
- Revenue This Year
- BLCO $8.27
- ACLX N/A
- Revenue Next Year
- BLCO $5.73
- ACLX $174.18
- P/E Ratio
- BLCO N/A
- ACLX N/A
- Revenue Growth
- BLCO 8.81
- ACLX N/A
- 52 Week Low
- BLCO $10.45
- ACLX $47.86
- 52 Week High
- BLCO $21.69
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- BLCO 59.83
- ACLX 59.74
- Support Level
- BLCO $15.00
- ACLX $70.11
- Resistance Level
- BLCO $15.50
- ACLX $78.61
- Average True Range (ATR)
- BLCO 0.34
- ACLX 2.62
- MACD
- BLCO 0.02
- ACLX 0.52
- Stochastic Oscillator
- BLCO 72.03
- ACLX 70.63
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.